Literature DB >> 16042917

Management of small intestinal bacterial overgrowth.

Gregg W Van Citters1, Henry C Lin.   

Abstract

Similar to that of all mammals, the human gastrointestinal tract is colonized by 100 trillion bacteria shortly after birth. Remarkably, in the open-tube arrangement of the intestine, this bacterial population is tightly compartmentalized to the distal gut. Contamination of the small intestine with colonic bacterial flora or small intestinal bacterial overgrowth (SIBO) has been understood previously as a complication of uncommon conditions associated with obvious intestinal stasis. However, SIBO has also been found in 78% to 84% of patients with the common condition of irritable bowel syndrome (IBS). In this paper, the diagnostic and treatment approaches to SIBO are reconsidered within the larger framework of the patient with IBS.

Entities:  

Mesh:

Year:  2005        PMID: 16042917     DOI: 10.1007/s11894-005-0025-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  14 in total

1.  Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization.

Authors:  A Sghir; G Gramet; A Suau; V Rochet; P Pochart; J Dore
Journal:  Appl Environ Microbiol       Date:  2000-05       Impact factor: 4.792

2.  Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria.

Authors:  H J Harmsen; G R Gibson; P Elfferich; G C Raangs; A C Wildeboer-Veloo; A Argaiz; M B Roberfroid; G W Welling
Journal:  FEMS Microbiol Lett       Date:  2000-02-01       Impact factor: 2.742

3.  Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria.

Authors:  Erja Malinen; Anna Kassinen; Teemu Rinttilä; Airi Palva
Journal:  Microbiology (Reading)       Date:  2003-01       Impact factor: 2.777

4.  Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.

Authors:  M Pimentel; E J Chow; H C Lin
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

5.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

6.  Human colonic biota studied by ribosomal DNA sequence analysis.

Authors:  K H Wilson; R B Blitchington
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

7.  Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.

Authors:  Liam O'Mahony; Jane McCarthy; Peter Kelly; George Hurley; Fangyi Luo; Kersang Chen; Gerald C O'Sullivan; Barry Kiely; J Kevin Collins; Fergus Shanahan; Eamonn M M Quigley
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

8.  Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption.

Authors:  Mark Pimentel; Yuthana Kong; Sandy Park
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

Review 9.  Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome.

Authors:  Henry C Lin
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

10.  Effect of colonic fermentation on respiratory gas exchanges measured in the postabsorptive state.

Authors:  D Heresbach; B Flouríe; F Briet; L Achour; J C Rambaud; B Messing
Journal:  Am J Clin Nutr       Date:  1995-11       Impact factor: 7.045

View more
  15 in total

Review 1.  Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.

Authors:  S C Shah; L W Day; M Somsouk; J L Sewell
Journal:  Aliment Pharmacol Ther       Date:  2013-09-04       Impact factor: 8.171

2.  Treatment of functional diarrhea.

Authors:  Evan S Dellon; Yehuda Ringel
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

3.  Antibiotics for the treatment of irritable bowel syndrome.

Authors:  Robert J Basseri; Stacy Weitsman; Gillian M Barlow; Mark Pimentel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-07

Review 4.  Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.

Authors:  Bushra Aziz Malik; Yuan Y Xie; Eytan Wine; Hien Q Huynh
Journal:  Can J Gastroenterol       Date:  2011-01       Impact factor: 3.522

5.  A hundred-year-old insight into the gut microbiome!

Authors:  Ramy Karam Aziz
Journal:  Gut Pathog       Date:  2009-12-07       Impact factor: 4.181

6.  Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Authors:  Sergio Peralta; Claudia Cottone; Tiziana Doveri; Piero Luigi Almasio; Antonio Craxi
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

7.  Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Authors:  I Esposito; A de Leone; G Di Gregorio; S Giaquinto; L de Magistris; A Ferrieri; G Riegler
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

8.  Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.

Authors:  Xiang Jun Shen; John F Rawls; Thomas Randall; Lauren Burcal; Caroline N Mpande; Natascha Jenkins; Biljana Jovov; Zaid Abdo; Robert S Sandler; Temitope O Keku
Journal:  Gut Microbes       Date:  2010-05-13

Review 9.  Breath tests and irritable bowel syndrome.

Authors:  Satya Vati Rana; Aastha Malik
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 10.  Antibiotics for irritable bowel syndrome: rationale and current evidence.

Authors:  Amit H Sachdev; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.